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Background: Given a lack of markers, diagnoses of bipolar disorder (BD) and major 
depressive disorder (MDD) rely on clinical assessment of symptoms. However, the 
depressive mood states of BD and depressive symptoms of MDD are often difficult to 
distinguish, which leads to misdiagnoses, which in turn leads to inadequate treatment. 
Previous studies have shown that the hemodynamic responses of the left frontopolar 
cortex measured by near-infrared spectroscopy (NIRS) differ between BD and MDD; 
these hemodynamic responses are associated with altered mitochondrial metabolism; 
and mitochondrial DNA copy number (mtDNAcn), an index of mitochondrial dysfunction, 
tends to decrease in BD and increase in MDD patients. In this study, we confirmed that 
mtDNAcn trends in opposite directions in BD and MDD. We then determined whether 
mtDNAcn could enhance the utility of NIRS as a diagnostic marker to distinguish between 
BD and MDD.
Methods: We determined mtDNAcn in peripheral blood samples from 58 healthy controls, 
79 patients with BD, and 44 patients with MDD. Regional hemodynamic responses during 
a verbal fluency task (VFT) in 24 BD patients and 44 MDD patients, matched by age and 
depression severity, were monitored using NIRS.
Results: Measurements of mtDNAcn were lower in BD patients and higher in MDD patients 
than in controls. The left frontopolar region exhibited the most significant differences 
in mean VFT-related oxy-Hb changes between the BD and MDD groups. Multivariate 
logistic regression analysis with variables including age, sex, hemodynamic response of 
the left frontopolar region, and mtDNAcn showed high accuracy for distinguishing BD 
from MDD (area under the curve = 0.917; 95% confidence interval = 0.849–0.985). For 
the BD group, we observed a positive correlation between hemodynamic responses 
in the left frontopolar region and mtDNAcn, while for the MDD group, we observed a 
negative correlation.
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INTRODUCTION
Bipolar disorder (BD) and major depressive disorder (MDD) are 
severe mental disorders that cause long-term disability. Diagnoses 
of both diseases rely on clinical assessment of symptoms, due 
to the lack of available molecular or brain-imaging diagnostic 
tests available; however, the depressive mood state of BD and 
depressive symptoms of MDD are often confused with each 
other, which could lead to inadequate medical treatment (1).
As a diagnostic test for these disorders, near-infrared 
spectroscopy (NIRS) has gained increasing interest. NIRS is a 
noninvasive method for recording brain electrical activity by 
focal increases in cerebral blood flow (2). Previous NIRS studies 
have reported differential hemodynamic responses, primarily 
in the left frontopolar cortex, during verbal fluency tasks (VFTs) 
between BD patients, MDD patients, and healthy controls (3–7), 
consistent with findings from other neuroimaging techniques, 
including functional magnetic resonance imaging (fMRI) (8, 9). 
A multicenter, collaborative NIRS study reported that left frontal 
hemodynamic responses during VFTs were diagnostic for MDD 
with 75% accuracy and BD with 77% accuracy (10), although 
some skepticism regarding the diagnostic accuracy of NIRS, 
particularly the overdiagnosis of BD relative to MDD, remains 
(11). Considering the clinical need, diagnostic markers for 
distinguishing between BD and MDD may be much more valuable 
than markers for diagnosing BD or MDD relative to controls.
Previous physiological studies have reported that hemodynamic 
responses are associated with the metabolism of mitochondrial 
chromophores or with the cytochrome c oxidase redox state (2, 
12). Accumulating evidence supports a role for mitochondrial 
dysfunction in pathophysiological differences between psychiatric 
disorders (13). BD has been associated with decreased mitochondrial 
electron transport chain activity and increased oxidative stress; 
moreover, multiple studies have reported an association between 
BD and the presence of mitochondrial DNA (mtDNA) variants 
(14). The mtDNA copy number, or mtDNAcn, has been used as 
an index of mitochondrial dysfunction and investigated in many 
diseases, including mood disorders (15–17). Recently, our meta-
analysis showed that mtDNAcn was lower in BD patients than in 
controls in an Asian population (18). Furthermore, a large-scale 
study demonstrated that mtDNAcn was higher in MDD patients 
than in controls (19). These results suggest that mtDNAcn exhibits 
converse trends in BD and MDD; however, to date no single study 
has investigated these differences in BD and MDD simultaneously.
Therefore, in this study, we first confirmed that mtDNAcn 
exhibits converse trends in BD and MDD, and then determined 
whether mtDNAcn enhances the utility of NIRS as a marker to 
distinguish between BD and MDD.
MATERIALS AND METHODS
Participants
For mtDNAcn measurement, patients who were clinically 
diagnosed with BD (n = 79, mean age ± standard deviation = 
43.4 ± 12.4 years), patients with MDD (n = 44, 42.9 ± 10.8 years), 
and healthy controls (CON; n = 58, 48.2 ± 13.1 years) from the 
Osaka, Kobe, and Tokushima city areas of Japan (Hondo) (6, 18, 20, 
21) were recruited between April 2013 and March 2017. All patients 
participated in this study via outpatient consultations. The gender 
distributions for the BD, MDD, and CON patient groups were 
(male/female) 40/39, 31/13, and 29/29, respectively. Diagnoses of 
BD or MDD were made using the criteria of DSM-IV or DSM-5.
Patients diagnosed with BD not otherwise specified (BD-NOS) 
and mixed features were excluded. Other exclusion criteria included 
a history of head trauma with loss of consciousness, current or 
previous neurological diseases, current or previous endocrine 
diseases, alcohol/substance abuse or addiction within the past 
12 months, a history of electroconvulsive therapy, and comorbid 
anxiety disorder. Healthy controls were required to have no present, 
past, or first-degree relative history of psychiatric disorders, or 
any other current serious medical disorder. This study complied 
with the Declaration of Helsinki and was approved by the Ethics 
Committee of each institute. A portion of the data generated and 
analyzed during this study was included in our previous article (18).
Regional hemodynamic responses during a VFT in 24 
patients with BD and 44 with MDD (matched by age and 
depression severity) were monitored by NIRS (Table 1). All 68 
patients were diagnosed using the Japanese version of the Mini 
International Neuropsychiatric Interview (22) with DSM. All 
were diagnosed to be in a euthymic or depressive state on the 
day of scanning. Among the BD patients, 14 exhibited bipolar 
I disorder and 10 exhibited bipolar II disorder. Percentages of 
depressed and euthymic patients were 58% (14) and 42% (10) of 
the BD group, and 59% (26) and 40% (18) of the MDD group, 
respectively.
Assessment of Symptoms
Severity of depression was evaluated using the 17-item Hamilton 
Depression Rating Scale (HDRS17), administrated using a 
Conclusions: Our findings suggest that the association between hemodynamic response 
and mitochondrial dysfunction in BD or MDD plays an important role in differentiating the 
pathophysiological mechanisms of BD from those of MDD.
Keywords: bipolar disorder, major depressive disorder, hemodynamics, mitochondria, near-infrared spectroscopy
Abbreviations: ATP, adenosine-5’-triphosphate; AUC, area under the curve; 
BD, bipolar disorder; CI, confidence interval; CT, cortical thickness; deoxy-HB, 
deoxygenated hemoglobin; fMRI, functional magnetic resonance imaging; GAF, 
global assessment of functioning; HDRS, Hamilton Depression Rating Scale; MDD, 
major depressive disorder; mtDNAcn, mitochondrial DNA copy number; NIRS, 
near-infrared spectroscopy; oxy-Hb, oxygenated hemoglobin; OR, odds ratio; ROC, 
receiver operating characteristic; SE, standard error; VFT, verbal fluency task; YMRS, 
Young mania rating scale; (1)H MRS, proton magnetic resonance spectroscopy.
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structured interview guide (23). Manic symptoms were assessed 
using the Young Mania Rating Scale (YMRS) (24). All patients 
with BD had a YMRS total score of 8 or less. Global functioning 
was assessed with the Global Assessment of Functioning (GAF) 
(21). IQ was estimated using the Japanese version of the National 
Adult Reading Test (25). Daily doses of all antidepressants and 
antipsychotics were converted to equivalent doses of imipramine 
and chlorpromazine, respectively (26).
Measurement of mtDNAcn
DNA was extracted from peripheral whole blood samples using 
the QIAamp DNA Blood Midi Kit (Qiagen Inc., Valencia, CA), 
and quantified using a NanoDrop spectrophotometer (Thermo 
Scientific, Wilmington, DE). The mtDNAcn was calculated 
by measuring the amount of mtDNA (NADH dehydrogenase, 
subunit 1 [ND1]) relative to that of the nuclear gene HGB as 
previously described (27). All qPCR experiments were performed 
using a 7500 Real-Time PCR System (Applied Biosystems, Foster 
City, CA), with SYBR Green Master Mix (Applied Biosystems, 
Foster City, CA). The forward and reverse primer sequences 
and cycling conditions for the ND1 gene were 5’-AAC ATA 
CCC ATG GCC AAC CT and 5’-AGC GAA GGG TTG TAG 
TAG CCC, respectively, with an initial heating step of 95°C for 
10 min, followed by 40 cycles of 95°C for 15 s, 58°C for 20 s, 
and 72°C for 20 s. The forward and reverse primer sequences and 
cycling conditions for the HGB gene were 5’-GCT TCT GAC 
ACA ACT GTG TTC ACT AGC and 5’-CAC CAA CTT CAT 
CCA CGT TCA CC, respectively, with an initial heating step of 
95°C for 10 min, followed by 40 cycles of 95°C for 15 s, 58°C for 
20 s, and 72°C for 20 s. Each sample was amplified in triplicate, 
using 10 ng of DNA. Amplification of ND1 and the single-copy 
gene HGB was performed in separate runs, using the same 
reference sample in the same well positions. A standard curve 
from a five-point serial-dilution series with reference DNA was 
constructed. Laboratory personnel who performed the assays 
were blinded to the identities and group memberships of the 
patients; moreover, all demographic data, as well as the sample 
order, were randomized in each batch of amplifications.
Near-Infrared Spectroscopy
We used a 52-channel NIRS device (ETG-4000 Optical Topography 
System; Hitachi Medical Co., Tokyo, Japan) to measure changes 
in regional cortical Hb concentration in frontotemporal regions 
during cognitive activation as described previously (28, 29). 
Probes (17 emitters and 16 detectors, alternating) were fixed 
using 3 × 11 thermoplastic shells with an inter-optode distance of 
3.0 cm. Each adjoining pair of an emitter and detector was referred 
to as a “channel,” resulting in 52 channels in total (Figure  1). 
The lowermost probes were positioned along the Fp1–Fp2 line, 
according to the International 10–20 system. The probes measure 
Hb values bilaterally from the prefrontal and temporal surface 
regions, at a depth of 20–30 mm from the scalp, which corresponds 
roughly to the depth of the surface of the cerebral cortex.
NIRS measures relative changes in oxy- and deoxy-Hb 
concentrations using two wavelengths (695 and 830 nm) of near-
infrared light, based on the modified Beer–Lambert law (30). 
However, NIRS cannot measure the absolute path length from the 
emitter to the detector. We therefore recorded relative mean changes 
in Hb concentration from the baseline in mM∙mm. The time 
resolution of signal acquisition was 0.1 s. Mean changes in task-related 
oxy-Hb levels were calculated by a linear fit to two baseline periods: 
the final 10 s of the pre-task period and the final 5 s of the post-task 
period (integral mode). We set the moving average window to 5 s to 
remove high-frequency noise from sources including heartbeats 
and small movements. Data from some channels were excluded for 
an excessive level of artifacts using a computer algorithm described 
TABLE 1 | Demographics of patients with bipolar disorder and patients with major depressive disorder.
Patients with BD (n = 24) Patients with MDD (n = 44) χ2/t/U P value
Age (years) 40.2 ± 9.3 42.9 ± 10.8 t = 1.05 0.30
Females (n, %) 12 (50.0) 13 (30) χ2 = 2.80 0.10
Estimated IQa 108.3 ± 8.8 105.8 ± 8.4 U = 446.0 0.36
Duration of illness (years) 11.4 ± 6.3 9.0 ± 8.2 U = 371.0 0.04
Antidepressant user (n, %)





χ2 = 3.24 0.07
Antipsychotic user (n, %)





χ2 = 3.88 0.05
Mood stabilizer user (n, %) 12 (50) 8 (18) χ2 = 7.57 <0.01
Mean daily dose (mg)b
- Lithium 510 ± 181 533 ± 149
- Sodium valproate 600 ± 424 300 ± 0.0
- Carbamazepine 300 ± 0.0 −
- Lamotrigine 81.3 ± 48.0 50 ± 0.0
HDRS17 8.6 ± 6.1 9.8 ± 6.5 U = 473.5 0.48
YMRSa 2.3 ± 2.8 0.5 ± 1.2 U = 322.0 <0.01
GAF 57.8 ± 14.9 61.6 ± 13.6 U = 431.0 0.21
VFT performances 16.0 ± 4.2 15.4 ± 5.6 t = 0.45 0.65
mtDNAcn 0.71 ± 0.36 0.92 ± 0.42 U = 3490 0.02
BD, bipolar disorder; GAF, global assessment of functioning; HDRS, Hamilton Depression Rating Scale; MDD, major depressive disorder; mtDNAcn, mitochondrial DNA copy 
number; VFT, verbal fluency task; YMRS, Young mania rating scale.
aData were missing for one MDD patient.
bMean daily dose was calculated only for users for antidepressants, antipsychotics, and each mood stabilizer, respectively.
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previously (31); thus, the number of available channels varied among 
individuals, but mean numbers of channels did not differ between 
the groups [BD: mean ± SD, 49.7 ± 3.4; and MDD: mean ± SD, 
49.4 ± 3.2; Mann–Whitney U test, U = 499.0, p = 0.70].
The spatial information for each channel was estimated using 
data from the Functional Brain Science Laboratory at the Jichi 
Medical University, Japan (32–34). The locations of NIRS channels 
in frontotemporal regions were estimated and anatomically 
labeled in the Chris Rorden MRIcro region of highest probability.
Activation Task
Changes in hemoglobin levels were stimulated using VFTs 
because previous studies have shown measurable prefrontal 
activation during VFTs in healthy subjects (4, 29). The task 
procedure was similar to that described previously (28, 29). 
VFTs used in the present study included a 30-s pre-task baseline 
period, a 60-s task period comprising three 20-s blocks, and a 
70-s post-task baseline period. During the pre- and post-task 
baseline periods, the subjects were instructed to repeat a train of 
syllables (“a, i, u, e, and o”). During the 60-s task, subjects were 
asked to generate as many words as possible that begin with that 
syllable. The possible syllables were: block 1 (0–20 s), “a,” “to,” or 
“na”; block 2 (20–40 s), “i,” “ki,” or “se”; and block 3 (40–60 s), 
“o,” “ta,” or “ha.” The number of correct words represented the 
subject’s performance score.
Statistical Analysis
Demographic and clinical variables were compared between the 
study groups using a χ2 test for categorical variables and a t-test or 
Mann–Whitney U-test for continuous variables. The threshold for 
statistical significance was set at P < 0.05 (two-tailed). Regression 
analyses, performed using generalized linear models, a gamma 
distribution, and a log link, were used as needed to determine 
whether mtDNAcn variations between the patient groups were 
associated with covariates such as patient age and sex. Dummy 
variables [phenotype, control = 0, case (BD or MDD) = 1; sex, 
male = 1 and female = 2] were used where necessary.
To identify regional differences between the groups in 
hemodynamic responses of the 52 channels, mean oxy-Hb 
changes with normal distribution were compared using a t-test or 
the changes with non-normal distribution were compared using 
Mann–Whitney U-test with a Bonferroni-corrected P-value of 
<0.05 (i.e., 0.05/52; P = 0.001). Channel 38, which showed the 
most significant differences between BD and MDD for mean VFT-
related oxy-Hb changes, and mtDNAcn were further examined 
as candidate biomarkers for distinguishing BD from MDD, using 
multivariate logistic regression analysis. Area under the receiver 
operating characteristic (ROC) curve analyses were used to 
measure discriminatory power. To test the relationships between 
mean oxy-Hb changes and demographic and clinical variables, 
we calculated Spearman correlation coefficients, again with a 
Bonferroni-corrected P-value of <0.05 (i.e., 0.05/52; P = 0.001).
All statistical tests were performed using IBM SPSS Statistics 
(version 22.0; IBM Corporation, Armonk, NY, USA) and R 
(version 3.4.1; The R Foundation for Statistical Computing, 
Vienna, Austria) software.
RESULTS
mtDNAcn Differences Among Bipolar 
Disorder, Major Depressive Disorder, 
and Healthy Control Groups
Our regression analysis after adjusting for age and sex showed that 
patients with BD had a significantly lower mtDNAcn (β = −0.014, 
P = 0.034) than that of healthy controls; in contrast, patients with 
MDD had a significantly higher mtDNAcn than that of healthy 
controls (β = 0.108, P = 0.012; Figure 2, Supplementary Table 1).
Demographics for Near-Infrared 
Spectroscopy Study
Compared with the MDD group, the BD group had a significantly 
longer duration of illness (P = 0.043), as well as larger ratios 
of  antipsychotic usage (P = 0.049) and mood stabilizer usage 
FIGURE 1 | Locations of near-infrared spectroscopy channels for recording functional hemodynamics in the frontotemporal area (dorsolateral prefrontal, ventrolateral 
prefrontal, frontopolar, and temporal areas).
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(P = 0.006). In clinical variables, the BD group had higher scores 
on the YMRS, compared with the MDD group (P = 0.001), 
whereas group differences were not observed in VFT performance 
(P = 0.651). Table 1 summarizes the demographic and clinical 
characteristics of the study groups.
Near-Infrared Spectroscopy Data
Oxy-Hb Measurements in Bipolar Disorder 
and Major Depressive Disorder Groups
Differences in oxy-Hb levels over time between the BD and MDD 
patient groups were clearly observed from the middle to the end 
of the VFT (Figure 3A and B; for details, see Supplementary 
Figure 1).
Differences in Mean Oxy-Hb Changes between Bipolar 
Disorder and Major Depressive Disorder Groups
The BD group exhibited significantly larger mean VFT-related 
oxy-Hb changes than the MDD group in four channels (ch17, 
ch27, ch38, and ch48; Bonferroni-corrected P < 0.001; Table 2, 
Supplementary Table 2). Among these four channels, ch38 
exhibited the most significant difference in mean VFT-related 
oxy-Hb changes between the BD and MDD groups (t = 4.39). 
Figure  3C shows differential time-course changes in oxy-Hb 
levels between groups for a representative channel, ch38, in the left 
frontopolar region. We found no significant differences between 
the BD subjects with (n = 4) and without (n = 20) medication 
(Supplementary Table 3) and between the MDD subjects with 
(n = 11) and without (n = 32) medication (Supplementary Table 4).
Lack of Correlations between Oxy-Hb Changes  
and Clinical Variables
We did not find any other significant correlations between mean 
VFT-related oxy-Hb changes for each channel and any clinical 
variables (age, sex, estimated IQ, duration of illness, or dosage of 
antidepressants, antipsychotics or each drug of mood stabilizers, 
HDRS17, YMRS, GAF) in either patient group.
Multivariate Logistic Regression Analysis
Multivariate logistic regression analysis was performed to 
determine whether mean VFT-related oxy-Hb changes in the 
channels, combined with mtDNAcn, age, and sex, could discriminate 
BD from MDD. On first review, the correlation analyses and scatter 
plots showed a significant linear relationship among all the four 
channels (Supplementary Figure 2). We selected ch38 because 
it showed the most significant difference in mean VFT-related 
oxy-Hb changes between BD and MDD (Table 2); moreover, ch38 
had a strong association with each of the other four channels. We 
performed a multivariate logistic regression analysis in which 
phenotype (BD/MDD) was the response variable, with age, sex, 
mean VFT-related oxy-Hb changes of ch38, mtDNAcn, and 
interaction between mean VFT-related oxy-Hb changes for ch38 
and mtDNAcn as the explanatory variables (Table 3). The resulting 
model showed high accuracy, with an area under the curve (AUC) 
of 0.917 [95% CI = 0.849–0.985] (Figure 4). We also tested the 
models with age and sex, and/or mean VFT-related oxy-Hb 
changes of ch38, and/or mtDNAcn without the interaction. These 
models were less accurate, with AUCs ranging from 0.608 to 0.855 
(Figure 4).
Differential Correlation between NIRS Data  
and mtDNAcn
We investigated the relationship between mean VFT-related 
oxy-Hb changes for ch38 and mtDNAcn, as the interaction 
FIGURE 2 | The mtDNA copy numbers of control subjects and patients 
with bipolar or major depressive disorder. All P values were calculated using 
generalized linear models, considering patient age and sex. Error bars 
represent the standard error of the mean. CON, control; BD, bipolar disorder; 
MDD, major depressive disorder.
TABLE 2 | Comparison of VFT-related oxy-Hb changes of patients with bipolar disorder and those with major depressive disorder threshold, with Bonferroni-corrected 
P < 0.00096.
MNI coordinate
Estimated region R/L NIRS Ch x y z BD MDD t-value P-value
Frontopolar region L Ch17 −22 57 32 0.07 ± 0.10 −0.01 ± 0.07 3.647 0.00053
L Ch27 −13 68 20 0.10 ± 0.12 0.01 ± 0.08 3.824 0.00029
L Ch38 −24 68 9 0.13 ± 0.013 0.01 ± 0.09 4.392 0.00004
L Ch48 −13 72 −3 0.13 ± 0.016 0.01 ± 0.10 3.657 0.00053
BD, bipolar disorder; Ch, channel; MDD, major depressive disorder; VFT, verbal fluency task.
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FIGURE 3 | Time-course changes in oxygenated hemoglobin and deoxygenated hemoglobin levels in bipolar disorder (BD) and major depressive disorder (MDD). 
(A) Time-course changes in BD. (B) Time-course changes in MDD. In the BD group, oxy-Hb levels gradually increased after the start of the task period and 
decreased gradually in the post-task period mainly in the prefrontal channels, while the oxy-Hb levels in the MDD group were lower than those in the BD group in 
frontotemporal channels across the task period. (C) Differential time-course changes in oxy-Hb levels between BD and MDD groups, for a channel 38, in which a 
significant difference in VFT-related oxy-Hb levels was observed between study groups. Standard deviations are shown as pale red (BD) and blue-dotted (MDD) 
areas. The oxy-Hb levels of the BD group gradually increased after the start of the task period, while these of the MDD group were smaller across the task period.
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between these two variables had a strong effect on ROC analysis. 
Interestingly, the mtDNAcn of the BD group was significantly 
positively correlated with mean VFT-related oxy-Hb changes in 
ch38 (rho = 0.660, Bonferroni-corrected P < 0.00096), while that 
of the MDD group was significantly negatively correlated (rho = 
−0.541, Bonferroni-corrected P < 0.00096; Figure 5).
DISCUSSION
This study is the first to investigate the relationship of changes in 
mtDNAcn in both BD and MDD simultaneously. In addition, this 
is also the first NIRS study to combine hemodynamic response 
data with mtDNAcn data. First, we showed that BD is likely 
associated with a reduction of mitochondrial DNA content and 
that BD patients exhibit changes in mtDNAcn that contrast with 
those exhibited by MDD patients. Next, we confirmed that the 
NIRS and mtDNAcn data from this study were consistent with 
data from previous studies; the differences in mean VFT-related 
oxy-Hb changes between BD and MDD appeared most significant 
in the left frontopolar region. Thus, we performed ROC analyses 
using Oxy-Hb changes of the left frontopolar region and mtDNAcn 
in order to determine whether the addition of mtDNAcn 
data increases the efficacy of NIRS as a diagnostic marker for 
distinguishing between BD and MDD. Notably, our ROC analysis 
achieved an AUC value of 0.917, which is far greater than those 
from previous studies using only NIRS data (approximately 0.75). 
We hypothesize that this increase is at least partially derived from 
our observation that the direction of the relationships between 
the oxy-Hb changes of the left frontopolar region (ch38) and 
mtDNAcn in this study was opposite in BD (rho = 0.66) and 
MDD (rho = −0.54). On the other hand, the strong correlation we 
observed between hemodynamic responses and mtDNAcn was 
only visible in the left prefrontal cortex, not in other brain regions.
FIGURE 4 | The receiver operating characteristic curves from multivariate logistic regression models. Multivariate logistic regression analysis [the response variable: 
phenotype (bipolar disorder, BD/major depressive disorder, MDD) using the explanatory variables age, sex, VFT-related oxy-Hb changes for channel 38, mitochondrial 
DNA copy number (mtDNAcn), and interaction between mean VFT-related oxy-Hb changes of ch38 and mtDNAcn] showed high accuracy [area under the curve 
(AUC) = 0.917 (95% CI = 0.849–0.985)].
TABLE 3 | Multivariate logistic regression analysis of bipolar disorder (BD)/major depressive disorder (MDD) with ch38 and mitochondrial DNA copy number (mtDNAcn).
Variable Ba SE P-value OR 95% CI Percentage 
of correct 
classificationsLower Upper
Age 0.015 0.040 0.708 1.015 0.938 1.099 BD = 81.8%
MDD = 90.5%
Overall = 87.5%
Sex 1.866 0.817 0.022 6.465 1.303 32.081
ch38 30.917 11.345 0.006 2.67.E+13 5.90.E+3 1.21.E+23
mtDNAcn −4.320 1.867 0.021 0.0133 0.000343 0.516
ch38*mtDNAcn 65.295 25.814 0.011 2.28.E+28 2.42.E+6 2.14.E+50
Constant −3.239 2.345 0.167
A multivariate logistic regression analysis was performed to examine the ability to discriminate BD from MDD. Phenotype (BD/MDD) was the response variable, and age, sex, 
ch38, mtDNAcn, and interaction between ch38 and mtDNAcn, which was calculated after centering with each average, were the explanatory variables. The model χ2 test showed 
significance (χ2 = 41.016, df = 5, P < 0.001), and the individual variables also showed significance (P < 0.05) except age and constant. Hosmer and Lemeshow test showed that the 
regression formula was adequate (P = 0.424). The percentage of correct classifications was 87.5%.
aB, unstandardized partial regression coefficient.
SE, standard error; OR, odds ratio; CI, confidence interval.
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Consistent with our focus on the left frontopolar region, 
previous neuroimaging studies in BD subjects revealed abnormal 
cortical thickness (CT) and dysfunction, primarily in the left frontal 
cortex. A recent, large study by the Bipolar Disorder Working 
Group within the ENIGMA Consortium found that the left rostral 
middle frontal cortex was one of the regions in which BD subjects 
exhibited the greatest reduction in CT (35). Interestingly, an MRI 
study of both BD and MDD subjects found significantly thinner 
CT in the left rostral middle frontal and frontopolar cortex in BD, 
but not in MDD (36). Furthermore, a proton magnetic resonance 
spectroscopy ((1)H MRS) study detected abnormal cellular energy 
and phospholipid metabolism in the left dorsolateral prefrontal 
cortex of medication-free individuals with BD, suggesting the 
presence of mitochondrial dysfunction in the left prefrontal cortex 
(37). Another study hypothesized that the VFT used in this study 
requires three shifts in mindset in rapidly switching from one 
phoneme to another; therefore, this task might be more sensitive 
to left prefrontal lobe deficits than VFTs that require fewer shifts 
(38). This hypothesis is consistent with previous neuroimaging 
studies using fMRI (39) and NIRS (4). In this context, previous 
NIRS studies using VFTs found alterations of oxy-Hb changes in 
frontotemporal regions in MDD, BD, or schizophrenia patients, 
particularly in the left frontopolar region (4, 5, 31).
In quantitative mtDNA, we used regression analysis with age 
and sex as covariates because both age and sex are well known to 
affect mtDNAcn; there is a positive relationship between age and 
mtDNAcn, as well as a higher mtDNAcn in females than in males 
(40). Some previous studies have reported lower mtDNAcn in 
peripheral blood of BD patients (15) and higher in MDD patients 
(19), although conflicting results exist (16, 17, 41). Some studies 
have found an association between mtDNAcn in peripheral 
blood and mtDNAcn in brain tissues (42, 43). Further, Cataldo 
et al. found that the postmortem BD prefrontal cortex samples 
had reduced numbers of mitochondria (44). Thus, aberrant 
mtDNAcn changes are likely to occur not only in peripheral 
blood but also in the brains of BD and MDD patients.
Because the mechanisms of the differences between oxy-Hb 
changes of the left frontopolar region in BD and MDD and the 
biological importance of mtDNAcn increases and decreases in 
peripheral blood remain unclear, our findings may be difficult 
to interpret; this seems to be the most important limitation in 
this study. The VFT as an activation task for NIRS measurement 
is regarded as a measure of executive dysfunction requiring 
efficient organization of verbal retrieval and recall, as well as 
self-monitoring aspects of cognition, effortful self-initiation, 
and inhibition of responses when appropriate (45). These 
characteristics of the task may contribute to differences in activity 
of the frontopolar region between BD and MDD. Further studies 
combining data from other measurements, such as fMRI and 
MRS, are needed to better understand the association(s) between 
mitochondrial dysfunction and neural activities in BD and MDD.
There were other limitations to our study. First, we were 
unable to exclude some potential confounders known to affect 
NIRS or mtDNAcn, such as smoking status and lifestyle factors 
(46–48). Second, we used peripheral whole-blood samples, 
including mixed leukocytes and platelets, for our mtDNAcn 
quantitation. However, there is evidence that whole-blood 
measurements are comparable to measurements in isolated 
lymphocytes (49), suggesting that this is unlikely to be an 
issue. Nonetheless, for studying psychiatric disorders such as 
BD or MDD, brain tissues are the standard target tissue. Third, 
the effect of psychotropic drugs on NIRS data and mtDNAcn 
should be considered. Indeed, most patients in this study were 
taking medications. Some studies have shown no association of 
antidepressant and mood stabilizer dosages with NIRS data in 
the prefrontal cortex (4, 50). In our study, the presence/absence 
of medication had no statistical effect on hemodynamic 
response in all channels, and the dosages of antidepressants, 
antipsychotics, and mood stabilizers were not correlated 
with hemodynamic responses in any channels. Fourth, it still 
remains to be determined whether clinical variables including 
duration of illness, mood state, and past episodes affect NIRS 
measurements. Previous reports have shown that neither the 
duration of illness nor the difference in mood state (euthymic 
or depressed) had any effect on the NIRS data (6, 51–53). In this 
study, we found no significant correlation between duration of 
FIGURE 5 | Relationships between mitochondrial DNA copy number and VFT-related oxy-Hb changes in bipolar disorder and major depressive disorder groups. A 
significant positive correlation between mtDNAcn and mean VFT-related oxy-Hb changes was found for the BD group, while a negative correlation was observed for 
the MDD group. The threshold for statistical significance was set at Bonferroni-corrected P < 0.00096.
mtDNA and Hemodynamics in Mood DisordersTsujii et al.
9 May 2019 | Volume 10 | Article 312Frontiers in Psychiatry | www.frontiersin.org
illness and oxy-Hb changes in either group of patients. Fifth, our 
cohort has a significant difference between the gender ratios of 
our BD and MDD groups, although some studies have found no 
gender differences in NIRS data, including in the left frontopolar 
region (54, 55). These suggest that confounding effects of these 
factors are unlikely. However, our future studies using NIRS 
should control for these clinical variables. Finally, our sample 
size was too small to draw conclusions, and did not include 
either healthy controls or independent replication cohort. In 
addition, the measurements of hemodynamic responses by 
NIRS were conducted only in a subset of the patients whose 
mtDNAcn was measured. We are deeply aware of the need to 
test whether the high AUC obtained in our ROC analysis can be 
replicated in a well-designed independent cohort.
In summary, we have shown that patients with BD have 
a lower mtDNAcn than controls; this contrasts with higher 
mtDNAcn in patients with MDD than controls. Our findings 
suggest that mtDNAcn may be useful as an additional diagnostic 
marker to add to hemodynamic response for distinguishing BD 
from MDD. Further, the directions of the relationship between 
the oxy-Hb changes of the left frontopolar region and mtDNAcn 
were opposite in BD and MDD. Our findings suggest that the 
association between hemodynamic response and mitochondrial 
dysfunction plays an important role in differentiating the 
pathophysiological mechanisms of BD from those of MDD.
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